A detailed history of Sterling Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Sterling Capital Management LLC holds 10,898 shares of EXAS stock, worth $730,492. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,898
Previous 11,732 7.11%
Holding current value
$730,492
Previous $623 Million 4.36%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$40.91 - $56.0 $34,118 - $46,704
-834 Reduced 7.11%
10,898 $596 Million
Q2 2025

Aug 06, 2025

BUY
$40.31 - $58.08 $213,522 - $307,649
5,297 Added 82.32%
11,732 $623 Million
Q1 2025

May 13, 2025

SELL
$43.04 - $58.51 $56,984 - $77,467
-1,324 Reduced 17.06%
6,435 $279 Million
Q4 2024

Feb 13, 2025

BUY
$49.33 - $71.97 $110,597 - $161,356
2,242 Added 40.64%
7,759 $436 Million
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $234,086 - $390,769
5,517 New
5,517 $376 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.